Table 2.
Patients’ and healthy controls’ characteristics
|
Whole group |
RR |
PP + SP |
Healthy controls |
|
|---|---|---|---|---|
| (n=414) | (n=273) | (n=141) | (n=414) | |
|
female/male |
264/150 |
179/94 |
85/56 |
264/150 |
|
♀ (%) |
(63.77 %) |
(65.56%) |
(60.3%) |
(63.77 %) |
|
Age, yy ± SD |
42.0±11.0 |
38.5±9.51 |
48.5±10.40* |
42.0±11.0 |
|
(range) |
(16.0-72.0) |
(17.0-70.0) |
(16.0-72.0) |
(16.0-72.0) |
|
onset, yy ± SD |
32.37±10.37 |
31.65±10.31 |
33.17±10.21 |
-- -- |
|
(range) |
(11.0-61.0) |
(14.0-61.0) |
(11.0-55.0) |
|
|
Duration, yy ± SD |
9.14±7.43 |
6.92±6.47 |
13.44±7.34* |
-- -- |
|
(range) |
(0.2-50.0) |
(0.2-50.0) |
(0.2-35.0) |
|
|
EDSS ± SD |
2.91±2.24 |
1.8±1.04 |
5.03±2.43* |
-- -- |
|
(range) |
(1.0-10.0) |
(1.0-7.0) |
(1.0-10.0) |
|
|
PI ± SD |
0.63±1.08 |
0.59±0.94 |
0.72±1.32* |
-- -- |
|
(range) |
(0.03-10.0) |
(0.03-10.0) |
(0.04-10.0) |
|
|
MSSS ± SD |
3.94±2.74 |
2.93±1.99 |
5.98±2.87* |
-- -- |
| (range) | (0.13-9.99) | (0.13-9.6) | (0.29-9.99) |
*P<0.0001, when compared to the RR group. Values shown are mean, standard deviation (SD), and (ranges).